Orchard Therapeutics
ORTX
$16.70
Share price
0.00%
Change (1 day)
244.33%
Change (1 year)
EPS for Orchard Therapeutics (ORTX)
EPS in 2023 (TTM): -$6.20
According to Orchard Therapeutics 's latest financial reports the company's current EPS (TTM) is -$6.20. In 2022 the company made an earnings per share (EPS) of -$11.80 an increase over its 2021 EPS that were of -$11.80.
EPS history for Orchard Therapeutics from 2018 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$6.20 | -47.46% |
| 2022 | -$11.80 | -0% |
| 2021 | -$11.80 | -22.98% |
| 2020 | -$15.32 | -12.45% |
| 2019 | -$17.50 | -90.11% |
| 2018 | -$176.87 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | -$2.06 | -66.77% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -$6.20 | 0.00% | 🇬🇧 UK |
 Novavax NVAX | -$7.19 | 15.97% | 🇺🇸 USA |
 Novocure
NVCR | -$1.86 | -70.00% | Jersey |